Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Rising drug prices are a top issue for voters. Photo: Education Images / UIG via Getty Images
The White House's Office of Management and Budget is officially evaluating a proposal from the Health and Human Services Department that would "lower drug prices and reduce out-of-pocket costs," ahead of President Trump's speech about drug prices next week.
The big picture: HHS and OMB did not respond when asked what was included, but the proposal likely will include ideas from Trump's budget that won't really target the pricing practices of pharmaceutical manufacturers.